mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.04 |
0.5 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
GDC-0449 |
FIMM |
pan-cancer |
AAC |
0.14 |
0.5 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.5 |